Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KSE - Delayed Quote KRW

GC Biopharma Corp. (006280.KS)

Compare
116,000.00
-1,200.00
(-1.02%)
At close: 3:30:14 PM GMT+9
All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-53,460,079.25
-53,460,079.25
-5,472,809.76
119,154,310.88
125,978,948.87
Investing Cash Flow
-67,894,169.56
-67,894,169.56
-150,243,304.36
-205,259,306.66
-132,077,425.35
Financing Cash Flow
93,845,334.70
93,845,334.70
100,511,823.14
-2,480,542.68
-41,270,328.74
End Cash Position
22,563,430.29
22,563,430.29
49,706,128.32
105,365,807.60
186,060,276.97
Capital Expenditure
-42,391,239.19
-42,391,239.19
-125,991,501.23
-94,690,240.05
-123,538,692.06
Issuance of Debt
1,500,526,868.40
1,500,526,868.40
1,193,247,000
836,759,000
1,078,929,270.56
Repayment of Debt
-1,378,846,000
-1,378,846,000
-1,060,216,000
-848,712,643.12
-1,088,187,010.56
Free Cash Flow
-95,851,318.44
-95,851,318.44
-131,464,310.99
24,464,070.83
2,440,256.81
12/31/2021 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade